nihonkohden

Financial Data

Latest Financial Results

1Q of FY2017 ending March 2018

Financial Highlights

  • Overall sales increased 6.2% over the first quarter of FY2016. In Japan, in order to respond to market changes such as the government's healthcare reforms, the Company absorbed and merged 11 domestic sales subsidiaries in April 2017, following the reorganization of sales operations in April 2016. Sales increased in all product categories as the Company enhanced sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. Internationally, sales in the Americas and Asia increased as the Company strengthened its sales & service network and expanded its product line-up of Patient Monitors.
  • As SG&A expenses increased mainly due to R&D investments, operating loss was ¥219 million.
Sales
Operating Income
Ordinary Income
Income Attributable to Owners of Parent
millions of yen
 
FY2016
1Q
FY2017
1Q
YoY
(%)
Sales
(Gross Profit Margin)
31,402
(48.7%)
33,353
(48.5%)
6.2
Operating Income
(Operating Income Margin)
-416
(-1.3%)
-219
(-0.7%)

 
Ordinary Income -1,472 158
Income Attributable to Owners of Parent -1,086 16
Average Exchange Rate
1 US Dollar ¥112.8 ¥111.9  
1 EURO ¥125.8 ¥121.9  

Sales by Product Category

  • Physiological Measuring Equipment: In Japan, sales of diagnostic information system and polygraphs for cath labs increased favorably. Sales of ECGs also increased. Sales of EEGs decreased. Internationally, sales of ECGs decreased in the U.S. and Asia. Sales of EEGs increased in Europe and Asia.
  • Patient Monitors: In Japan, sales of clinical information system and consumables such as sensors increased favorably. Internationally, sales showed strong growth in the Americas, Europe and Asia.
  • Treatment Equipment: In Japan, sales of defibrillators and ventilators increased favorably. Sales of AEDs also increased. Internationally, sales of AEDs decreased in all areas. Sales of defibrillators increased favorably in Asia. 
  • Other Medical Equipment: In Japan, sales of hematology instruments increased favorably. Internationally, sales of locally purchased products increased. Sales of hematology analyzers decreased in Asia. 
Sales by Product Category
millions of yen
  FY2016
1Q
FY2017
1Q
YoY
(%)
Physiological Measuring Equipment 7,896 8,342 5.7
Patient Monitors 9,862 11,217 13.7
Treatment Equipment 6,409 6,422 0.2
Other Medical Equipment 7,235 7,370 1.9
Total 31,402 33,353 6.2
(Reference)      
Consumables and Services 15,791 17,215 9.0

Sales by Region

  • Japan: Sales in the clinic market showed strong growth. Sales in the university and the private hospital market also increased. Sales in public hospital market decreased. 
  • International: In the Americas, sales in the U.S. increased favorably as there was partial shipment for orders of Patient Monitors which we received at the end of FY2016. Sales in Latin America also increased, primarily in Brazil. Sales in Europe slightly decreased, especially in Italy, while sales in Germany increased due to the enhancement of the sales network there. In Asia, sales in South Korea increased favorably and sales in India showed strong growth mainly due to a rush in demand prior to the GST implementation in July. Sales in China increased on a comparable basis and decreased on a yen basis. 
Domestic Sales
Overseas Sales
millions of yen
  FY2016
1Q
FY2017
1Q
YoY
(%)
Domestic Sales 23,878 24,887 4.2
Overseas Sales
(Overseas Sales Ratio)
7,524
(24.0%)
8,465
(25.4%)
12.5
Americas
3,369 4,234 25.7
Europe
1,527 1,518 -0.6
Asia
2,322 2,524 8.7
Other
304 188 -38.2